{
  "trial_id": "NCT00946920",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gleason score, Screening testosterone level, Prostate-specific antigen (PSA) level, Eastern Cooperative Oncology Group (ECOG) score, Life expectancy, History of hormone therapy, History of therapy with finasteride or dutasteride, History of severe untreated asthma, anaphylactic reactions, or severe urticaria and/or angioedema, History of heart insufficiency, History or presence of another malignancy, Clinically significant medical conditions, History of investigational drug use, Candidate for curative therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Median Baseline Serum Testosterone Levels (ng/mL)",
          "Screening testosterone level"
        ],
        [
          "Median Baseline Serum Prostate-specific Antigen Levels (ng/mL)",
          "Prostate-specific antigen (PSA) level"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race (NIH/OMB)",
        "Baseline Short Form-36 (SF-36) Total Scores",
        "Baseline Total International Prostate Symptom Scores (IPSS)"
      ],
      "remaining_candidate_features": [
        "Gleason score",
        "Eastern Cooperative Oncology Group (ECOG) score",
        "Life expectancy",
        "History of hormone therapy",
        "History of therapy with finasteride or dutasteride",
        "History of severe untreated asthma",
        "anaphylactic reactions",
        "or severe urticaria and/or angioedema",
        "History of heart insufficiency",
        "History or presence of another malignancy",
        "Clinically significant medical conditions",
        "History of investigational drug use",
        "Candidate for curative therapy."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Gleason Score, Baseline PSA Level, Baseline Testosterone Level, ECOG Performance Status, Life Expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Median Baseline Serum Testosterone Levels (ng/mL)",
          "Baseline Testosterone Level"
        ],
        [
          "Median Baseline Serum Prostate-specific Antigen Levels (ng/mL)",
          "Baseline PSA Level"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Race (NIH/OMB)",
        "Baseline Short Form-36 (SF-36) Total Scores",
        "Baseline Total International Prostate Symptom Scores (IPSS)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Gleason Score",
        "ECOG Performance Status",
        "Life Expectancy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity Not Collected, Region of Enrollment, Gleason Score, Screening Testosterone, PSA, ECOG Score, Life Expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Median Baseline Serum Testosterone Levels (ng/mL)",
          "Screening Testosterone"
        ],
        [
          "Median Baseline Serum Prostate-specific Antigen Levels (ng/mL)",
          "PSA"
        ],
        [
          "Baseline Short Form-36 (SF-36) Total Scores",
          "ECOG Score"
        ],
        [
          "Baseline Total International Prostate Symptom Scores (IPSS)",
          "Gleason Score"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity Not Collected",
        "Region of Enrollment",
        "Life Expectancy"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, weight, height, body mass index (BMI), Gleason score, prostate-specific antigen (PSA) level, Eastern Cooperative Oncology Group (ECOG) score, life expectancy, medical history (including history of malignancy, severe untreated asthma, anaphylactic reactions, severe urticaria and/or angioedema, heart insufficiency, renal, haematological, gastrointestinal, endocrine, cardiac, neurological, or psychiatric disease), current medications, prior hormone therapy, prior therapy with finasteride and dutasteride.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Median Baseline Serum Prostate-specific Antigen Levels (ng/mL)",
          "prostate-specific antigen (PSA) level"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Median Baseline Serum Testosterone Levels (ng/mL)",
        "Baseline Short Form-36 (SF-36) Total Scores",
        "Baseline Total International Prostate Symptom Scores (IPSS)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "weight",
        "height",
        "body mass index (BMI)",
        "Gleason score",
        "Eastern Cooperative Oncology Group (ECOG) score",
        "life expectancy",
        "medical history (including history of malignancy, severe untreated asthma, anaphylactic reactions, severe urticaria and/or angioedema, heart insufficiency, renal, haematological, gastrointestinal, endocrine, cardiac, neurological, or psychiatric disease)",
        "current medications",
        "prior hormone therapy",
        "prior therapy with finasteride and dutasteride."
      ]
    }
  }
}